Free Trial

Royal London Asset Management Ltd. Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Royal London Asset Management Ltd. raised its position in Colgate-Palmolive (NYSE:CL - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 445,623 shares of the company's stock after purchasing an additional 14,844 shares during the period. Royal London Asset Management Ltd. owned 0.05% of Colgate-Palmolive worth $46,260,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of CL. Park Avenue Securities LLC boosted its holdings in Colgate-Palmolive by 5.0% in the 2nd quarter. Park Avenue Securities LLC now owns 7,739 shares of the company's stock valued at $751,000 after purchasing an additional 371 shares during the period. CWM LLC lifted its holdings in shares of Colgate-Palmolive by 18.0% during the 2nd quarter. CWM LLC now owns 27,355 shares of the company's stock worth $2,655,000 after acquiring an additional 4,177 shares during the last quarter. Csenge Advisory Group lifted its holdings in shares of Colgate-Palmolive by 8.7% during the 2nd quarter. Csenge Advisory Group now owns 3,734 shares of the company's stock worth $362,000 after acquiring an additional 300 shares during the last quarter. Gilman Hill Asset Management LLC bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $213,000. Finally, QRG Capital Management Inc. lifted its holdings in shares of Colgate-Palmolive by 11.2% during the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company's stock worth $5,558,000 after acquiring an additional 5,751 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CL. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a report on Monday, October 28th. Stifel Nicolaus cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their price objective for the company from $107.00 to $109.00 in a research report on Monday, September 9th. StockNews.com upgraded shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, November 25th. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an "overweight" rating and a $121.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Read Our Latest Research Report on CL

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL traded down $0.87 during midday trading on Friday, reaching $94.23. The stock had a trading volume of 4,104,800 shares, compared to its average volume of 4,383,152. The stock has a 50-day moving average of $96.73 and a 200-day moving average of $98.61. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The company has a market capitalization of $76.99 billion, a price-to-earnings ratio of 27.00, a price-to-earnings-growth ratio of 3.38 and a beta of 0.43. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $0.50 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines